Study guide
Prescriptive Fitting Targets (NAL-NL2 vs. DSL m[i/o]) & Dynamic Range
Praxis Audiology 5343
Track your progress as you read
Finished sections get a check mark.
1 Acoustics, Psychoacoustics & Sound Measurement
Physics of Sound, Wave Propagation & Decibel Scales (SPL, HL, SL) Psychoacoustics, Equal Loudness Contours & Frequency Selectivity Speech Acoustics, Formant Structure & Auditory Perception
2 Auditory and Vestibular Anatomy and Physiology
Peripheral Auditory System: Outer, Middle & Inner Ear Transduction Vestibular End Organs, Semicircular Canals & Otolith Mechanics Central Auditory Pathways, Neuroanatomy & Lifespan Structural Maturation Auditory Behavior, Speech-Language Development & Effects of Hearing Loss Across the Lifespan
3 Auditory Pathologies, Genetics & Instrumentation
Outer, Middle, and Inner Ear Pathologies & Genetic Syndromes Nongenetic Systemic Conditions & Infectious Causes of Hearing and Balance Disorders Ototoxic Medications, Pharmacology & Monitoring Protocols Audiometric Instrumentation, Calibration Standards (ANSI S3.6) & Psychometrics
4 Prevention, Lifespan Screening & Hearing Conservation
Universal Newborn Hearing Screening & JCIH Protocols Pediatric and School-Age Hearing Screening Procedures Adult and Geriatric Hearing Screening & Self-Assessment Measures Screening for Speech-Language, Cognitive & Other Conditions and Screening Program Performance Occupational Hearing Conservation, Noise Exposure & OSHA Regulations Hearing Health Education, Fall-Risk Identification & Audiometric and Balance Monitoring
5 Behavioral Pure-Tone Audiometry & Masking
Clinical Preparation: Case History, Otoscopy & Selecting and Modifying Tests Air and Bone Conduction Pure-Tone Testing & Audiogram Interpretation Clinical Masking Principles, Interaural Attenuation & Plateau Method Non-Organic Hearing Loss, Pseudohypacusis & Stenger Testing
6 Speech Audiometry & Pediatric Behavioral Evaluation
Speech Detection & Recognition Thresholds (SDT/SRT) & Word Recognition (WRS) Speech-in-Noise Testing, PB-Max & Retrocochlear Rollover Diagnostics Central Auditory Processing Assessment: Dichotic, Temporal, Spatial & Low-Redundancy Tests Pediatric Behavioral Audiometry: BOA, VRA, and CPA
7 Acoustic Immittance & Middle Ear Diagnostics
Tympanometric Principles, Jerger Classification & Eustachian Tube Function Acoustic Reflex Thresholds, Reflex Arc Pathways & Reflex Decay Analysis Multi-Frequency Immittance, High-Frequency Probe Tones & Infant Protocols
8 Otoacoustic Emissions & Auditory Evoked Potentials
Transient and Distortion Product Otoacoustic Emissions (TEOAE & DPOAE) Auditory Brainstem Response (ABR) Diagnostic Protocols & Wave Analysis ASSR, Electrocochleography (ECochG) & Late Auditory Evoked Potentials
9 Vestibular & Balance Assessment
Videonystagmography (VNG), Oculomotor Tracking & Positional Nystagmus Bithermal Caloric Testing, Jongkees Formula & Rotational Chair Evaluation Video Head Impulse Test (vHIT), VEMP (cVEMP/oVEMP) & Dynamic Posturography (CDP) Integrating Assessment Results, Differential Diagnosis & Reporting
10 Hearing Aid Selection, Features & Prescriptive Fitting
Treatment Planning, Goal Setting, Progress Monitoring & Intervention Documentation Hearing Aid Components, Acoustic Transducers & Digital Signal Processing Prescriptive Fitting Targets (NAL-NL2 vs. DSL m[i/o]) & Dynamic Range CROS, BiCROS & Severe-to-Profound Fitting Strategies
11 Amplification Verification, Validation & Troubleshooting
Probe-Microphone Real-Ear Verification (REUR, REAR, REIG & RECD) ANSI S3.22 Electroacoustic Analysis & Quality Control Standards Clinical Validation Inventories (COSI, APHAB, SSQ) & Device Troubleshooting
12 Implantable Devices & Hearing Assistive Technology
Bone-Conduction Systems (BAHS) & Active Middle Ear Implants Cochlear Implants: Candidacy, Telemetry, MAPping Parameters & ABI Systems Hearing Assistive Technology, FM/DM Classroom Systems & Telecoils
13 Aural Rehabilitation, Tinnitus & Vestibular Management
Adult and Pediatric Aural Rehabilitation & Communication Strategies Tinnitus Management, Sound Therapy & Decreased Sound Tolerance Protocols Canalith Repositioning Maneuvers for BPPV & Vestibular Rehabilitation Therapy (VRT)
14 Ethics, Scope of Practice & Interprofessional Collaboration
ASHA and AAA Codes of Ethics, Ethical Decision-Making & Conflict of Interest Clinical Scope of Practice, CCC-A Credentialing, Licensure & Clinical Supervision Service Delivery Models, Practice Management, Risk Management & Advocacy Patient/Family Counseling & Interprofessional Practice in Education and Healthcare
15 Regulatory Compliance, Safety & Evidence-Based Practice
Federal Regulations (HIPAA, FERPA, ADA, OSHA), Billing Compliance & Infection Control Evidence-Based Practice, Research Methodology & Teleaudiology Service Delivery
Prescriptive Fitting Targets (NAL-NL2 vs. DSL m[i/o]) & Dynamic Range
Key Takeaways Explain This Topic AI
Prescriptive fitting formulas mathematically calculate target acoustic gain and compression ratios to restore speech audibility within the patient's narrowed dynamic range (DR), defined as the decibel difference between pure-tone thresholds and uncomfortable loudness levels (UCL / LDL).
Wide Dynamic Range Compression (WDRC) applies nonlinear gain using low threshold kneepoints (TK ≈ 40 − 50 dB SPL \approx 40-50\,\text{dB SPL} ≈ 40 − 50 dB SPL ) and mild compression ratios (CR ≈ 1.5 : 1 \approx 1.5:1 ≈ 1.5 : 1 to 3 : 1 3:1 3 : 1 ), delivering high gain for soft speech, moderate gain for conversational speech, and reduced gain for loud speech.
NAL-NL2 follows an intelligibility-maximization and loudness-equalization paradigm, equalizing perceived loudness across frequency bands while applying empirical corrections for patient age, gender, language tonal structure, and a 2 − 3 dB 2-3\,\text{dB} 2 − 3 dB bilateral fitting deduction.
DSL m[i/o] (Desired Sensation Level) follows a loudness-normalization paradigm, restoring normal loudness perception band-by-band; it is the most widely used pediatric prescription (AAA's 2013 pediatric guideline accepts validated methods such as DSL v5.0 or NAL-NL2) and typically prescribes more gain than NAL-NL2 to support speech and language learning.
Output limiting compression utilizes high kneepoints (TK > 85 − 90 dB SPL > 85-90\,\text{dB SPL} > 85 − 90 dB SPL ) and high compression ratios (CR ≥ 8 : 1 \ge 8:1 ≥ 8 : 1 ) to restrict maximum power output (OSPL90) strictly below individual measured LDLs, avoiding the severe harmonic distortion of peak clipping.
Last updated: October 2026
Prescriptive Fitting Targets (NAL-NL2 vs. DSL m[i/o]) & Dynamic Range
The fundamental goal of hearing aid electroacoustic fitting is to restore speech audibility across the audible frequency spectrum while maintaining auditory comfort and preventing acoustic trauma. Achieving this objective requires careful mapping of sound into the patient's restricted residual auditory dynamic range using scientifically validated prescriptive algorithms.
Dynamic Range of Hearing & Sensorineural Cochlear Loss
In healthy, normal-hearing human cochleae, the auditory dynamic range (DR) spans approximately 100 100 100 to 120 dB 120\,\text{dB} 120 dB across speech frequencies, extending from the threshold of audibility ( 0 dB HL 0\,\text{dB HL} 0 dB HL ) to the uncomfortable loudness level (UCL / LDL, typically 100 − 110 dB HL 100-110\,\text{dB HL} 100 − 110 dB HL ).
Dynamic Range (dB) = UCL (dB HL) − Hearing Threshold (dB HL) \text{Dynamic Range (dB)} = \text{UCL (dB HL)} - \text{Hearing Threshold (dB HL)} Dynamic Range (dB) = UCL (dB HL) − Hearing Threshold (dB HL)
Outer Hair Cell Damage & Loudness Recruitment
Sensorineural hearing loss (SNHL) primarily originates from structural damage to or loss of outer hair cells (OHCs) within the organ of Corti. Outer hair cells provide electromechanical motility (mediated by the motor protein prestin), acting as an active non-linear cochlear amplifier that boosts low-level sounds ( < 50 − 60 dB SPL < 50-60\,\text{dB SPL} < 50 − 60 dB SPL ) by up to 40 − 50 dB 40-50\,\text{dB} 40 − 50 dB while sharpening basilar membrane tuning curves.
When OHCs are damaged:
Threshold Elevation: Soft sounds are no longer amplified by the active cochlear mechanism, causing pure-tone threshold elevation ( 30 − 70 dB HL 30-70\,\text{dB HL} 30 − 70 dB HL ). Soft speech ( 45 − 55 dB SPL 45-55\,\text{dB SPL} 45 − 55 dB SPL ) becomes inaudible.
Abnormal Loudness Growth (Recruitment): As input levels rise to high intensities ( > 85 − 90 dB SPL > 85-90\,\text{dB SPL} > 85 − 90 dB SPL ), passive basilar membrane mechanics dominate. Passive fluid displacement stimulates remaining inner hair cells (IHCs) normally. Consequently, loud sounds are perceived just as loudly by an individual with SNHL as by an individual with normal hearing.
Dynamic Range Compression: Because the hearing threshold is elevated to 65 dB HL 65\,\text{dB HL} 65 dB HL while the UCL remains relatively unchanged at 100 dB HL 100\,\text{dB HL} 100 dB HL , the patient's dynamic range collapses from 100 dB 100\,\text{dB} 100 dB down to only 35 dB 35\,\text{dB} 35 dB .
Clinical UCL / LDL Measurement Protocol
The Fallacy of Assumed UCLs: Fitting software frequently defaults to assumed population average UCLs ( 100 dB HL 100\,\text{dB HL} 100 dB HL across all frequencies). Empirical measurements demonstrate that individual UCLs vary widely, ranging from 80 dB HL 80\,\text{dB HL} 80 dB HL to > 115 dB HL > 115\,\text{dB HL} > 115 dB HL . Relying on software defaults risks either under-amplifying loud speech inputs or causing acoustic pain and device rejection.
Standard Clinical Measurement Protocol:
Test stimuli: Frequency-specific pulsed pure tones ( 500 , 1000 , 2000 , 4000 Hz 500, 1000, 2000, 4000\,\text{Hz} 500 , 1000 , 2000 , 4000 Hz ) or speech-spectrum noise bursts delivered under calibrated insert earphones.
Rating scale: The Cox Contour Test for Loudness (Category 1: Very Soft; Category 2: Soft; Category 3: Comfortable, But Slightly Soft; Category 4: Comfortable; Category 5: Comfortable, But Slightly Loud; Category 6: Loud, But OK; Category 7: Uncomfortably Loud).
Procedure: Ascend in 5 dB 5\,\text{dB} 5 dB steps starting at comfortable listening levels ( 65 − 70 dB HL 65-70\,\text{dB HL} 65 − 70 dB HL ) until the patient signals Category 7: Uncomfortably Loud . Re-test to verify reliability within ± 5 dB \pm 5\,\text{dB} ± 5 dB . The hearing aid Maximum Power Output (MPO / OSPL90) is programmed directly below this empirical boundary.
Wide Dynamic Range Compression (WDRC) Mechanics
Linear amplification applies a fixed, identical gain factor across all input levels. In a collapsed dynamic range, a linear hearing aid providing 35 dB 35\,\text{dB} 35 dB of gain to make soft speech ( 50 dB SPL 50\,\text{dB SPL} 50 dB SPL ) audible would amplify loud conversational peaks ( 85 dB SPL 85\,\text{dB SPL} 85 dB SPL ) to 120 dB SPL 120\,\text{dB SPL} 120 dB SPL , causing loudness discomfort and potential acoustic trauma. Conversely, if gain is lowered to keep loud sounds comfortable, soft speech becomes inaudible. Wide Dynamic Range Compression (WDRC) resolves this trade-off by dynamically altering gain as a function of incoming signal intensity.
- Compression Architecture & Parameters Output (dB SPL)
- ^
- | Output Limiting (CR >= 8:1)
- | /-------------------------- MPO / OSPL90
- | / (High TK ~ 85-90 dB SPL)
- | /
- | WDRC /
- | (CR 1.5:1-3:1)/
- | /
- | Linear /
- | (CR = 1:1) /
- | / <-- Low TK (~40-50 dB SPL)
- +------------+------------------------------------> Input (dB SPL)
Compression Threshold / Kneepoint (TK): The input sound pressure level at which the amplifier transitions from linear amplification to compressed gain reduction.
WDRC Systems: Utilize low threshold kneepoints ( TK = 40 − 50 dB SPL \text{TK} = 40-50\,\text{dB SPL} TK = 40 − 50 dB SPL ). This guarantees that the softest phonemes of speech receive maximum acoustic gain to clear the elevated hearing threshold.
Compression Ratio (CR): The ratio of decibel input change to decibel output change along the compression slope: CR = Δ Input (dB) Δ Output (dB) \text{CR} = \frac{\Delta \text{Input (dB)}}{\Delta \text{Output (dB)}} CR = Δ Output (dB) Δ Input (dB)
A linear circuit has a CR = 1 : 1 \text{CR} = 1:1 CR = 1 : 1 (a 10 dB 10\,\text{dB} 10 dB increase in input yields a 10 dB 10\,\text{dB} 10 dB increase in output).
A WDRC circuit typically uses mild-to-moderate compression ratios: CR = 1.5 : 1 \text{CR} = 1.5:1 CR = 1.5 : 1 to 3.0 : 1 3.0:1 3.0 : 1 . At CR = 2 : 1 \text{CR} = 2:1 CR = 2 : 1 , a 10 dB 10\,\text{dB} 10 dB increase in input produces only a 5 dB 5\,\text{dB} 5 dB increase in output.
High compression ratios ( > 3.5 : 1 > 3.5:1 > 3.5 : 1 to 4.0 : 1 4.0:1 4.0 : 1 ) applied across wide bandwidths reduce speech contrast, flatten the temporal speech envelope, smear acoustic phoneme boundaries, and degrade speech recognition in noise.
Output Limiting Compression (Compression Limiting): Implemented at high input levels with a high threshold kneepoint ( TK ≥ 85 − 90 dB SPL \text{TK} \ge 85-90\,\text{dB SPL} TK ≥ 85 − 90 dB SPL ) and high compression ratio ( CR ≥ 8 : 1 \text{CR} \ge 8:1 CR ≥ 8 : 1 to 12 : 1 12:1 12 : 1 ). This strictly caps maximum output (OSPL90) below the patient's measured LDL while maintaining low harmonic distortion ( < 2 % < 2\% < 2% ), replacing legacy peak clipping.
Temporal Compression Parameters: Attack & Release Times
Attack Time ( t a t_a t a ): The time required for the compression circuit to reduce gain to within 2 − 3 dB 2-3\,\text{dB} 2 − 3 dB of its final steady-state value following an abrupt increase in input level ( > 10 − 20 dB > 10-20\,\text{dB} > 10 − 20 dB ). Standards mandate fast attack times ( 5 − 20 ms 5-20\,\text{ms} 5 − 20 ms ) to prevent sudden acoustic transients (e.g., slamming doors, clattering dishes) from exceeding the patient's discomfort threshold.
Release Time ( t r t_r t r ): The time required for the circuit to restore gain to within 2 − 3 dB 2-3\,\text{dB} 2 − 3 dB of its target value following a drop in input level.
Syllabic Compression (Fast Release: 50 − 100 ms 50-100\,\text{ms} 50 − 100 ms ): Gain recovers between syllables, amplifying weak consonants following loud vowels. Risk: Rapid gain changes amplify background noise during speech pauses, creating an audible breathing or "pumping" artifact.
Slow / Adaptive Compression (Release: 800 ms − 2.0 s 800\,\text{ms} - 2.0\,\text{s} 800 ms − 2.0 s ): Maintains stable gain across conversational sentences, preserving natural temporal envelope cues. Modern systems employ dual/adaptive release time algorithms : fast release for transient acoustic spikes, and slow release during continuous speech to maintain comfort and avoid pumping.
Compression Type Threshold Kneepoint (TK) Compression Ratio (CR) Attack Time Release Time Primary Clinical Objective
WDRC Low ( 40 − 50 dB SPL 40-50\,\text{dB SPL} 40 − 50 dB SPL ) Mild ( 1.5 : 1 − 3 : 1 1.5:1-3:1 1.5 : 1 − 3 : 1 ) Fast ( 5 − 20 ms 5-20\,\text{ms} 5 − 20 ms ) Dual/Adaptive ( 50 ms − 1.5 s 50\,\text{ms}-1.5\,\text{s} 50 ms − 1.5 s ) Maximize audibility of soft speech; maintain comfort for average speech
Output Limiting High ( > 85 − 90 dB SPL > 85-90\,\text{dB SPL} > 85 − 90 dB SPL ) High ( ≥ 8 : 1 \ge 8:1 ≥ 8 : 1 ) Ultra-Fast ( 1 − 10 ms 1-10\,\text{ms} 1 − 10 ms ) Fast-to-Moderate ( 50 − 100 ms 50-100\,\text{ms} 50 − 100 ms ) Protect against loudness discomfort / MPO exceedance; zero peak clipping
Peak Clipping Saturation limit Infinite ( ∞ : 1 \infty:1 ∞ : 1 ) Instantaneous ( < 1 ms < 1\,\text{ms} < 1 ms ) Instantaneous Legacy protection; introduces extreme harmonic distortion and splatter
Prescriptive Target Philosophies: NAL-NL2 vs. DSL m[i/o]
Modern clinical practice relies on two primary prescriptive target paradigms. While both utilize multichannel WDRC, they are derived from fundamentally contrasting psychoacoustic philosophies.
1. NAL-NL2 (National Acoustic Laboratories - Non-Linear 2)
Core Philosophy: Loudness Equalization & Intelligibility Maximization.
Developed by the Australian National Acoustic Laboratories (Dillon, Keidser, et al.).
NAL-NL2 calculates target gain across frequency bands such that each band contributes equally to overall perceived loudness. Instead of attempting to normalize loudness to match a healthy ear, NAL-NL2 balances loudness across bands to maximize the Speech Intelligibility Index (SII) while keeping overall perceived loudness at or below normal listening comfort.
Desensitization Factor: NAL-NL2 incorporates empirical cochlear desensitization data: as hearing loss exceeds 65 − 70 dB HL 65-70\,\text{dB HL} 65 − 70 dB HL , damaged inner hair cells and auditory nerve fibers lose the capacity to extract useful spectral and temporal information. Pumping high gain into severe hearing loss bands causes physiological distortion. NAL-NL2 deliberately compresses or limits target gain at frequencies with severe-to-profound loss, focusing amplification where residual hearing can extract intelligible speech cues.
Empirical Patient Adjustments:
Bilateral Fitting Correction: Because central binaural loudness summation increases perceived loudness by 2 − 3 dB 2-3\,\text{dB} 2 − 3 dB at low-to-moderate levels and up to 5 − 6 dB 5-6\,\text{dB} 5 − 6 dB at high input levels, NAL-NL2 reduces prescribed gain by ≈ 2 − 3 dB \approx 2-3\,\text{dB} ≈ 2 − 3 dB per ear when programmed for bilateral use.
Age Adjustment: Recognizes that adults over 60 years demonstrate reduced auditory processing and intolerance for excessive high-frequency loudness; prescribes slightly reduced gain for older adults.
Gender Correction: Prescribes approximately 1 − 2 dB 1-2\,\text{dB} 1 − 2 dB more gain for adult males than females based on empirical loudness preference differences.
Language Structure (Tonal vs. Non-Tonal): Prescribes slightly greater low-frequency gain ( < 1 kHz < 1\,\text{kHz} < 1 kHz ) for tonal language speakers (e.g., Mandarin, Cantonese) to preserve fundamental frequency pitch contours critical for lexical meaning.
Experience Level: Prescribes slightly reduced gain ( 2 − 4 dB 2-4\,\text{dB} 2 − 4 dB ) for new, inexperienced hearing aid users, transitioning to full prescriptive targets via adaptive acclimatization algorithms.
2. DSL m[i/o] (Desired Sensation Level Multistate Input/Output)
Core Philosophy: Loudness Normalization across Sensation Levels.
Developed at the University of Western Ontario (Seewald, Scollie, et al.).
DSL operates on a loudness normalization philosophy: it aims to make soft sounds sound soft, conversational sounds sound average, and loud sounds sound loud, recreating the normal loudness growth curve within each individual frequency band.
Most Widely Used Pediatric Prescription:
DSL v5.0 is the most widely used prescription for infants and children in North America. The AAA (2013) pediatric amplification guideline calls for a validated, age-appropriate prescriptive method, such as DSL v5.0 or NAL-NL2.
Developmental Rationale: Unlike adults, who have established central phonemic representations, children cannot use top-down cognitive context to fill in missing acoustic cues. Children require access to the entire acoustic speech spectrum—including weak, high-frequency consonant fricatives ( / s / , / z / , / θ / /s/, /z/, /\theta/ / s / , / z / , / θ / )—to acquire spoken language, learn morphological markers (plurals, possessives, verb tenses), and monitor their own vocal feedback.
DSL usually prescribes higher overall gain than NAL-NL2 for the identical audiogram (often several decibels more, especially in the low and mid frequencies) across soft, average, and loud input levels.
Incorporates child-specific Real-Ear-to-Coupler Difference (RECD) corrections to account for the smaller acoustic volume and higher resonant frequency of the infant/child ear canal.
Parameter NAL-NL2 DSL m[i/o]
Underlying Philosophy Loudness Equalization (maximize speech intelligibility at comfortable overall loudness) Loudness Normalization (restore normal loudness perception at each discrete frequency band)
Primary Target Population Adults (presbycusis, acquired occupational / recreational loss) Pediatrics (infants, children, developmental language acquisition)
Relative Gain Prescribed Lower overall gain (typically several dB less than DSL for children) Higher overall gain (greater audibility across low, mid, and high frequencies)
Handling of Severe Loss Reduces gain at severe loss frequencies due to cochlear desensitization Maintains gain to maximize full-spectrum sensation level
Bilateral Correction Automatic 2 − 3 dB 2-3\,\text{dB} 2 − 3 dB gain reduction per ear to account for binaural summation Separate unilateral and bilateral targets with conservative correction
Demographic Corrections Gender, age, hearing aid experience level, language structure (tonal vs. non-tonal) Age-based acoustic corrections primarily driven by RECD and canal resonance